| Code | Description | Claims | Beneficiaries | Total Paid |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,179 |
967 |
$375K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,321 |
1,783 |
$293K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17,288 |
1,801 |
$249K |
| 93000 |
|
13,437 |
1,856 |
$218K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,616 |
1,853 |
$180K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,037 |
1,796 |
$117K |
| 85018 |
|
12,312 |
1,669 |
$94K |
| 82962 |
|
13,998 |
1,830 |
$57K |
| 81002 |
|
9,222 |
1,210 |
$54K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,728 |
668 |
$51K |
| 36415 |
Collection of venous blood by venipuncture |
803 |
257 |
$43K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
13,254 |
1,207 |
$43K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,840 |
1,187 |
$40K |
| 85048 |
|
10,753 |
1,300 |
$26K |
| 99215 |
Prolong outpt/office vis |
1,031 |
224 |
$24K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,379 |
642 |
$18K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,438 |
1,581 |
$13K |
| 81025 |
|
9,766 |
1,268 |
$13K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,233 |
212 |
$12K |
| 81003 |
|
8,643 |
1,004 |
$11K |
| 96376 |
|
1,303 |
102 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
609 |
131 |
$7K |
| J7070 |
Infusion, d5w, 1000 cc |
2,586 |
560 |
$4K |
| 85027 |
|
3,269 |
480 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,782 |
394 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16,445 |
1,785 |
$3K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
366 |
72 |
$3K |
| 82948 |
|
3,368 |
506 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
10,198 |
1,129 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
120 |
90 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
2,040 |
325 |
$806.23 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
21 |
18 |
$568.40 |
| 94010 |
|
52 |
31 |
$383.44 |
| 96127 |
|
439 |
140 |
$244.00 |
| 99491 |
Ccm add 20min |
157 |
123 |
$115.56 |
| J0895 |
Injection, deferoxamine mesylate, 500 mg |
39 |
12 |
$70.27 |
| 36416 |
|
12,641 |
1,235 |
$50.90 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
304 |
188 |
$50.20 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
226 |
71 |
$48.35 |
| A4301 |
Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.) |
5,565 |
569 |
$13.48 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
73 |
14 |
$1.99 |
| 99072 |
|
15 |
12 |
$0.00 |
| G2064 |
Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities |
26 |
15 |
$0.00 |